Andrea Gardoni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrea Gardoni has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Elisabetta Sarasso
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
6 shared publications - Federica Agosta
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute , Milan 20132
6 shared publications - Massimo Filippi
Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
5 shared publications - Lucia Zenere
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
4 shared publications Elisa Canu
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
3 shared publications- Angela Marotta
Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
2 shared publications
Latest Publications
- Open Access
- 6 August 2026
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 133 (9) , 2733-2743
Multimodal assessment of clinical and neural changes following multidisciplinary management in functional motor disorders
Functional motor disorders (FMD) are common and disabling conditions, but objective biomarker changes following multidisciplinary management remain limited. Our objective was to investigate changes and responsiveness of multimodal biomarkers in individuals with FMD undergoing multidisciplinary management. 34 patients with clinically definite FMD (mean age 42.76 ± 11.01 years; 85.7% female; mean disease duration 0.64 ± 1.52 years) underwent a standardized multimodal assessment at baseline and 3-month follow-up after a multidisciplinary program. The intervention included a 5-day intensive rehabilitation program (2 h/day), followed by a 12-week phase of telemedicine (one session every 2 weeks) and home-based self-management (two sessions/week). Multimodal biomarkers across motor, exteroceptive, interoceptive, and brain function domains were assessed using clinical, neurophysiological, and task-based functional MRI measures. Motor symptoms improved with concurrent gains in depressive symptoms, physical quality of life, and fatigue (all, p < 0.047). Specific improvements were observed in motor performance, including reduced stride time variability during cognitive dual-tasking ( p = 0.018) and enhanced postural stability mainly in the eyes-closed condition (all, p < 0.028), while neurophysiological and nociceptive measures remained unchanged. Patients showed altered baseline brain activity compared with controls; post-intervention changes were observed in motor, cerebellar, and fronto-insular regions ( p < 0.001, uncorrected), without correlations with clinical outcomes. Multidisciplinary management in FMD was associated with improved clinical outcomes and specific motor and neural changes, suggesting domain-specific responsiveness and a potential role for multimodal biomarkers, requiring confirmation in larger controlled studies. Trial Registration number NCT06328790. Registered on 26 March 2024.
- 6 August 2026
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 133 (9) , 2733-2743
Open AccessMultimodal assessment of clinical and neural changes following multidisciplinary management in functional motor disorders
Functional motor disorders (FMD) are common and disabling conditions, but objective biomarker changes following multidisciplinary management remain limited. Our objective was to investigate changes and responsiveness of multimodal biomarkers in individuals with FMD undergoing multidisciplinary management. 34 patients with clinically definite FMD (mean age 42.76 ± 11.01 years; 85.7% female; mean disease duration 0.64 ± 1.52 years) underwent a standardized multimodal assessment at baseline and 3-month follow-up after a multidisciplinary program. The intervention included a 5-day intensive rehabilitation program (2 h/day), followed by a 12-week phase of telemedicine (one session every 2 weeks) and home-based self-management (two sessions/week). Multimodal biomarkers across motor, exteroceptive, interoceptive, and brain function domains were assessed using clinical, neurophysiological, and task-based functional MRI measures. Motor symptoms improved with concurrent gains in depressive symptoms, physical quality of life, and fatigue (all, p < 0.047). Specific improvements were observed in motor performance, including reduced stride time variability during cognitive dual-tasking ( p = 0.018) and enhanced postural stability mainly in the eyes-closed condition (all, p < 0.028), while neurophysiological and nociceptive measures remained unchanged. Patients showed altered baseline brain activity compared with controls; post-intervention changes were observed in motor, cerebellar, and fronto-insular regions ( p < 0.001, uncorrected), without correlations with clinical outcomes. Multidisciplinary management in FMD was associated with improved clinical outcomes and specific motor and neural changes, suggesting domain-specific responsiveness and a potential role for multimodal biomarkers, requiring confirmation in larger controlled studies. Trial Registration number NCT06328790. Registered on 26 March 2024.
- Open Access
- 30 April 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (5)
Identifying diagnostic biomarkers in functional motor disorders through multimodal behavioral, neurophysiological, and imaging assessment using explainable machine learning
Functional motor disorders (FMDs) represent a frequent and disabling neurological condition. The lack of reliable diagnostic biomarkers and their heterogeneity might affect diagnosis. We identified multimodal biomarkers distinguishing FMDs from healthy controls (HCs) using machine-learning approaches. In this multicenter cross-sectional study, consecutive adults with a clinically established FMDs diagnosis (n = 75, 74.7% female; mean age 44.20 ± 12.92) and age- and sex-matched HCs (n = 75; 58.6% female; 48.42 ± 11.67) were recruited. All participants underwent standardized behavioral, neurophysiological, and brain MRI assessment exploring motor, exteroceptive, and interoceptive domains. A Random Forest (RF) classifier combined with repeated stratified k-fold cross-validation was trained on the collected features. Predictive performance was evaluated using accuracy, sensitivity, specificity, precision, F1-score, and AUC-ROC. SHapley Additive exPlanations interpreted feature importance. The strongest diagnostic biomarkers were lower dual-task effect scores for postural sway area under eyes-closed motor and cognitive conditions, and gait speed during the motor dual-task, followed by increased vDMN and basal ganglia networks functional connectivity, reduced baseline ipsilateral-contralateral R2 blink reflex area, and higher DNIC-to-baseline N2P2 amplitude ratios for the lower limb. The RF classifier achieved robust performance (accuracy 85.0%, sensitivity 83.9%, specificity 86.1%, F1-score 85.7%, AUC-ROC 0.921). Motor, functional neuroimaging, and neurophysiological markers demonstrated diagnostic value in distinguishing FMDs from healthy controls, addressing the current lack of objective tools and supporting more confident and accurate diagnosis of these heterogeneous conditions. Trial registration number NCT06328790. Registered on 26 March 2024.
- 30 April 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (5)
Open AccessIdentifying diagnostic biomarkers in functional motor disorders through multimodal behavioral, neurophysiological, and imaging assessment using explainable machine learning
Functional motor disorders (FMDs) represent a frequent and disabling neurological condition. The lack of reliable diagnostic biomarkers and their heterogeneity might affect diagnosis. We identified multimodal biomarkers distinguishing FMDs from healthy controls (HCs) using machine-learning approaches. In this multicenter cross-sectional study, consecutive adults with a clinically established FMDs diagnosis (n = 75, 74.7% female; mean age 44.20 ± 12.92) and age- and sex-matched HCs (n = 75; 58.6% female; 48.42 ± 11.67) were recruited. All participants underwent standardized behavioral, neurophysiological, and brain MRI assessment exploring motor, exteroceptive, and interoceptive domains. A Random Forest (RF) classifier combined with repeated stratified k-fold cross-validation was trained on the collected features. Predictive performance was evaluated using accuracy, sensitivity, specificity, precision, F1-score, and AUC-ROC. SHapley Additive exPlanations interpreted feature importance. The strongest diagnostic biomarkers were lower dual-task effect scores for postural sway area under eyes-closed motor and cognitive conditions, and gait speed during the motor dual-task, followed by increased vDMN and basal ganglia networks functional connectivity, reduced baseline ipsilateral-contralateral R2 blink reflex area, and higher DNIC-to-baseline N2P2 amplitude ratios for the lower limb. The RF classifier achieved robust performance (accuracy 85.0%, sensitivity 83.9%, specificity 86.1%, F1-score 85.7%, AUC-ROC 0.921). Motor, functional neuroimaging, and neurophysiological markers demonstrated diagnostic value in distinguishing FMDs from healthy controls, addressing the current lack of objective tools and supporting more confident and accurate diagnosis of these heterogeneous conditions. Trial registration number NCT06328790. Registered on 26 March 2024.
- 8 September 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (9) , 1-11
Construct validity, intrarater and interrater reliability of the Italian version of the systematic screening of handwriting difficulties (SOS) test in people with Parkinson’s disease
Background The "Systematic Screening of Handwriting Difficulties in Parkinson’s Disease" (SOS) test is the only tool specifically designed to evaluate handwriting in people with Parkinson's Disease (pwPD). It is language specific. Objective To assess the construct validity, intrarater and interrater reliability of the Italian version of the SOS test. Methods Thirty-five pwPD and 15 healthy controls (HC) completed the Italian version of the SOS test. Participants copied an Italian text for 5 min on blank paper using a pen. Two independent raters evaluated writing speed, letter size, and handwriting quality according to the SOS test criteria. Correlations between the Italian SOS test scores, fine motor skills, and PD characteristics were analysed using Spearman's Rho correlation coefficient (ρ). Group comparisons were adjusted for education level using ANCOVA. Intrarater and interrater reliability were calculated using the intraclass correlation coefficient (ICC) or Kendall’s Tau (Kτ) coefficient depending on data distribution. Results The Italian version of the SOS test showed significant correlations between writing speed and fine motor skills in pwPD (ρ = 0.40; p = 0.016). PwPD showed significantly smaller letter size (η2p = 0.15; p = 0.006), lower writing speed (η2p = 0.18; p = 0.002), and lower writing quality (η2p = 0.12; p = 0.015) compared to HC. Intrarater reliability was excellent (ICCs > 0.990 and Kτ > 0.762 for pwPD; ICCs > 0.923 for HC), as was interrater reliability (ICCs > 0.860 and Kτ = 0.999 for pwPD; ICCs > 0.925 for HC). Conclusion The Italian version of the SOS test is a valid and reliable tool for clinically assessing handwriting in Italian-speaking pwPD. Clinical trial registration: https://clinicaltrials.gov/: NCT04876352, prospectively registered on May 6th 2021.
- 8 September 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (9) , 1-11
Construct validity, intrarater and interrater reliability of the Italian version of the systematic screening of handwriting difficulties (SOS) test in people with Parkinson’s disease
Background The "Systematic Screening of Handwriting Difficulties in Parkinson’s Disease" (SOS) test is the only tool specifically designed to evaluate handwriting in people with Parkinson's Disease (pwPD). It is language specific. Objective To assess the construct validity, intrarater and interrater reliability of the Italian version of the SOS test. Methods Thirty-five pwPD and 15 healthy controls (HC) completed the Italian version of the SOS test. Participants copied an Italian text for 5 min on blank paper using a pen. Two independent raters evaluated writing speed, letter size, and handwriting quality according to the SOS test criteria. Correlations between the Italian SOS test scores, fine motor skills, and PD characteristics were analysed using Spearman's Rho correlation coefficient (ρ). Group comparisons were adjusted for education level using ANCOVA. Intrarater and interrater reliability were calculated using the intraclass correlation coefficient (ICC) or Kendall’s Tau (Kτ) coefficient depending on data distribution. Results The Italian version of the SOS test showed significant correlations between writing speed and fine motor skills in pwPD (ρ = 0.40; p = 0.016). PwPD showed significantly smaller letter size (η2p = 0.15; p = 0.006), lower writing speed (η2p = 0.18; p = 0.002), and lower writing quality (η2p = 0.12; p = 0.015) compared to HC. Intrarater reliability was excellent (ICCs > 0.990 and Kτ > 0.762 for pwPD; ICCs > 0.923 for HC), as was interrater reliability (ICCs > 0.860 and Kτ = 0.999 for pwPD; ICCs > 0.925 for HC). Conclusion The Italian version of the SOS test is a valid and reliable tool for clinically assessing handwriting in Italian-speaking pwPD. Clinical trial registration: https://clinicaltrials.gov/: NCT04876352, prospectively registered on May 6th 2021.
- 28 January 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 120, 106015
Cervical motion alterations and brain functional connectivity in cervical dystonia
- 28 January 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 120, 106015
Cervical motion alterations and brain functional connectivity in cervical dystonia
- 22 September 2023
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 116, 105858
Action observation and motor imagery improve motor imagery abilities in patients with Parkinson’s disease – A functional MRI study
- 22 September 2023
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 116, 105858
Action observation and motor imagery improve motor imagery abilities in patients with Parkinson’s disease – A functional MRI study
- 1 October 2021
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 91, 88-95
Dual-task clinical and functional MRI correlates in Parkinson's disease with postural instability and gait disorders
- 1 October 2021
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 91, 88-95
Dual-task clinical and functional MRI correlates in Parkinson's disease with postural instability and gait disorders